Novo Nordisk A S (NONOF) stock
NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$38.24−0.60 (-1.53%)
Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –
Novo Nordisk A S shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
For fiscal 2025 it was 4.45B, down 0.3% from the year before. Over ten years it grew -1.5% a year on average. The highest annual figure on record is 5.16B in fiscal 2015.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.45B | -0.3% |
| FY2024 | Dec 31, 2024 | 4.46B | -0.7% |
| FY2023 | Dec 31, 2023 | 4.49B | -1.1% |
| FY2022 | Dec 31, 2022 | 4.54B | -1.3% |
| FY2021 | Dec 31, 2021 | 4.61B | -1.6% |
| FY2020 | Dec 31, 2020 | 4.68B | -1.6% |
| FY2019 | Dec 31, 2019 | 4.76B | -1.9% |
| FY2018 | Dec 31, 2018 | 4.85B | -2.2% |
| FY2017 | Dec 31, 2017 | 4.96B | -2.2% |
| FY2016 | Dec 31, 2016 | 5.07B | -1.7% |
| FY2015 | Dec 31, 2015 | 5.16B | – |
See a number that looks wrong?